Decreased cross-sectional muscle area in male patients with clear cell renal cell carcinoma and peritumoral collateral vessels

doi:10.4329/wjr.v14.i4.82

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 4

This Article

(207)

(197)

(0)

(13)

(1)

(4519)

(3)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Radiology

ISSN

1949-8470

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

- Full Article with Cover (PDF)
- Full Article (XML)

Retrospective Cohort Study

World J Radiol. Apr 28, 2022; 14(4): 82-90
Published online Apr 28, 2022. doi: 10.4329/wjr.v14.i4.82

Full Size Figure Download Figure

Figure 4 Kaplan-Meier curves showing no statistically significant difference of survival between the two groups (ccRCCa group is depicted as blue curve and ccRCCb group is depicted as red curve).

Citation: Greco F, Beomonte Zobel B, Mallio CA. Decreased cross-sectional muscle area in male patients with clear cell renal cell carcinoma and peritumoral collateral vessels. World J Radiol 2022; 14(4): 82-90
URL: https://www.wjgnet.com/1949-8470/full/v14/i4/82.htm
DOI: https://dx.doi.org/10.4329/wjr.v14.i4.82

Greco F, Beomonte Zobel B, Mallio CA. Decreased cross-sectional muscle area in male patients with clear cell renal cell carcinoma and peritumoral collateral vessels. World J Radiol 2022; 14(4): 82-90 [PMID: 35646290 DOI: 10.4329/wjr.v14.i4.82]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.